rfhg_163017.1

Basic information about the TSS

---

TSS ID: rfhg_163017.1 Species: human Chr: chr13		Start: 113309812 End: 113309825 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC006345:-27 GeneID: 3916 HGNC/MGI_ID: HGNC:6499 UniProt_ID: Nearer transcript ids and distances:

Gene_name: lysosomal associated membrane protein 1 Gene_symbol: LAMP1 Gene_synonyms: CD107a Gene_source: HGNC:6499

TATA-Box annotation

---

Distance to TSS:	12579
Nearest PromoterID:	NM_005561
Entrez ID:	3916
Nearest Unigene:	Hs.494419
Nearest Refseq:	NM_005561
Nearest Ensembl:	ENSG00000185896
Gene Name:	lysosomal associated membrane protein 1
Gene Alias:	CD107a|LAMPA|LGP120
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.214286
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@LAMP1 p2@LAMP1 p3@LAMP1 p4@LAMP1
Sample		p1@LAMP1	p2@LAMP1	p3@LAMP1	p4@LAMP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	157.40	12.66	3.31	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	156.39	9.51	3.03	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	159.53	10.80	1.93	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	128.90	9.98	2.70	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	139.25	12.15	2.25	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	140.71	15.50	2.52	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	134.65	14.38	2.83	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	145.57	14.05	2.66	1.21
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	134.64	14.53	1.28	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	102.01	20.87	2.90	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	70.74	18.19	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	90.66	13.01	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	286.92	3.55	9.03	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	244.62	4.51	6.77	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	269.39	3.07	6.81	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	251.24	4.78	4.53	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	246.80	3.93	6.33	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	244.65	4.22	6.33	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	266.58	4.80	5.86	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	241.31	3.16	5.87	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	240.17	3.47	7.75	1.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	224.07	3.63	5.87	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	229.95	4.52	4.91	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	232.72	3.40	7.28	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	232.71	3.61	3.87	2.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	231.05	3.48	8.23	3.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	257.70	6.59	6.59	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	248.95	4.01	8.02	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	246.00	4.04	7.27	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	245.93	4.16	7.06	1.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	232.16	3.35	5.65	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	252.82	3.91	7.03	2.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	245.22	3.17	5.49	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	234.05	6.43	5.11	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	223.64	4.49	6.54	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	263.29	3.07	6.90	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	232.79	3.68	7.36	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	226.87	3.83	7.66	3.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	259.30	3.24	4.59	3.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	247.74	3.36	6.72	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	240.44	3.53	7.06	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	238.18	4.83	5.27	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	231.35	2.74	7.80	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	249.30	3.32	7.87	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	250.77	3.21	6.63	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	248.00	5.58	7.44	3.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	272.05	2.88	10.08	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	241.72	4.77	5.96	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	278.63	4.55	6.94	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	262.25	4.45	7.08	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	260.09	5.94	3.89	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	268.18	4.45	6.45	1.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	125.93	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	255.50	4.26	5.32	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	254.50	5.96	5.96	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	215.61	7.55	3.36	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	221.81	5.51	4.13	3.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	257.34	2.92	7.13	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	267.53	3.21	6.74	2.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	248.95	6.60	6.29	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	243.95	4.94	5.64	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	252.92	5.05	2.80	2.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	363.84	8.76	10.35	6.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	221.87	3.06	2.38	3.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	228.42	5.20	4.22	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	255.94	3.19	5.68	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	113.15	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	134.26	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	218.41	3.90	6.34	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	228.60	4.96	1.49	3.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	205.47	5.16	2.81	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	248.39	3.31	3.64	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	231.70	5.26	4.02	4.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	242.46	3.97	6.42	1.53
Adipocyte - breast, donor1	11376-118A8	403.88	9.82	6.02	1.43
Adipocyte - breast, donor2	11327-117E4	451.28	9.95	9.30	3.05
Adipocyte - omental, donor1	11473-119C6	421.00	13.74	10.05	0.38
Adipocyte - omental, donor2	11474-119C7	388.70	15.70	11.21	5.23
Adipocyte - omental, donor3	11475-119C8	473.24	9.38	11.72	2.68
Adipocyte - perirenal, donor1	11476-119C9	403.85	8.93	8.93	5.74
Adipocyte - subcutaneous, donor1	11259-116F8	178.12	1.10	5.50	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	287.23	10.84	5.42	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	286.38	5.21	6.43	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	524.92	13.30	14.47	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	559.80	11.58	11.32	3.35
Adipocyte differentiation, day04, donor3	13025-139E1	619.71	26.76	14.77	2.79
Adipocyte differentiation, day04, donor4	13028-139E4	533.73	10.58	7.64	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	369.19	10.30	7.16	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	710.38	24.85	9.04	4.52
Adipocyte differentiation, day08, donor3	13026-139E2	416.42	23.46	9.60	3.73
Adipocyte differentiation, day08, donor4	13029-139E5	382.27	8.90	7.23	2.23
Adipocyte differentiation, day12, donor1	13021-139D6	316.08	11.64	8.73	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	582.20	21.10	12.56	3.27
Adipocyte differentiation, day12, donor3	13027-139E3	363.90	11.45	6.87	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	261.85	10.05	6.09	0.91
Alveolar Epithelial Cells, donor1	11510-119G7	273.15	9.50	5.52	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	209.41	5.02	2.87	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	245.59	4.79	2.40	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	416.66	16.01	9.00	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	523.80	10.04	6.69	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	460.82	11.30	10.07	1.64
Anulus Pulposus Cell, donor1	11248-116E6	238.23	5.72	5.61	1.83
Anulus Pulposus Cell, donor2	11463-119B5	236.34	6.12	4.90	2.20
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	258.34	9.44	7.19	5.84
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	330.82	6.95	3.47	4.78
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	241.85	4.28	12.84	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	294.14	6.88	5.98	5.38
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	290.87	11.38	6.32	11.38
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	254.13	8.58	5.94	3.96
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	284.28	9.10	8.12	1.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	330.59	12.14	10.68	4.85
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	250.02	8.91	4.16	4.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	264.78	4.90	5.65	6.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	288.82	4.35	10.16	4.35
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	234.46	17.55	3.76	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	255.18	7.91	7.91	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	298.89	15.01	13.65	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	211.26	5.88	3.62	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	337.01	9.11	8.04	6.43
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	324.02	8.88	7.94	3.78
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	297.76	8.29	7.48	5.08
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	335.56	8.78	6.83	6.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	284.45	8.79	5.47	2.65
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	214.93	1.20	6.00	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	311.53	7.08	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	298.63	10.81	7.89	2.23
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	171.99	16.78	8.39	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	323.78	9.71	5.83	6.80
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	299.77	9.49	7.97	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	239.85	7.27	4.85	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	286.73	13.68	9.69	4.56
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	323.01	7.27	6.63	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	275.64	5.68	6.97	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	319.53	10.32	7.51	3.28
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	289.07	10.61	8.68	3.22
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	231.16	7.85	2.14	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	284.87	6.43	4.68	3.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	319.74	6.32	4.22	3.91
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	255.42	5.94	10.69	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	289.88	7.12	5.09	4.58
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	247.30	7.13	6.62	4.84
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	199.51	4.45	10.17	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	304.66	6.47	8.20	3.88
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	262.28	5.93	5.72	2.75
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	248.80	5.51	4.64	2.90
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	338.22	7.56	7.56	4.72
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	277.00	6.95	5.09	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	264.07	2.32	4.63	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	323.22	12.68	4.23	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	333.84	8.36	8.15	2.79
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	267.74	6.62	7.82	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	277.01	5.10	2.19	8.02
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	256.32	8.05	5.52	2.99
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	298.39	2.55	10.20	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	225.50	7.88	6.86	1.53
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	336.50	7.02	6.40	4.13
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	279.99	7.96	7.96	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	290.15	8.60	11.47	8.60
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	308.88	9.98	8.43	3.99
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	242.60	1.53	4.58	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	280.82	7.20	9.42	3.88
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	315.90	7.94	7.41	2.91
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	253.69	7.27	5.45	4.36
Astrocyte - cerebellum, donor1	11500-119F6	263.20	5.16	7.98	0.49
Astrocyte - cerebellum, donor2	11580-120F5	330.17	6.33	9.41	0.68
Astrocyte - cerebellum, donor3	11661-122F5	294.07	5.87	7.97	1.47
Astrocyte - cerebral cortex, donor1	11235-116D2	194.86	4.18	4.88	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	230.37	3.40	7.28	2.10
Astrocyte - cerebral cortex, donor3	11392-118C6	204.80	3.43	3.88	1.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	113.65	2.41	1.83	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	123.53	3.76	3.13	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	116.76	4.44	1.71	0.68
Basophils, donor1	12241-129G9	191.70	6.80	2.62	0.00
Basophils, donor2	12242-129H1	271.32	9.38	2.53	0.00
Basophils, donor3	12243-129H2	191.54	3.23	3.38	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	321.25	16.39	5.39	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	258.77	4.11	6.86	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	373.03	14.35	7.17	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	114.23	2.51	2.51	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	178.84	3.12	2.91	0.62
Bronchial Epithelial Cell, donor6	11461-119B3	151.53	4.38	2.53	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	256.96	7.38	5.94	3.06
Burkitt's lymphoma cell line:DAUDI	10422-106C8	61.01	7.63	1.03	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	82.22	2.33	2.56	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	122.15	8.63	4.16	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	20.68	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	141.45	2.25	1.69	0.00
CD14+ Monocytes, donor2	11305-117B9	211.40	3.16	2.41	1.30
CD14+ Monocytes, donor3	11381-118B4	205.05	3.07	1.10	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	637.70	17.83	9.91	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	862.02	67.10	7.20	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	939.54	49.31	9.53	3.62
CD14+ monocytes - mock treated, donor1	11863-125A9	250.50	6.94	3.90	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	250.45	13.58	2.72	1.81
CD14+ monocytes - mock treated, donor3	11883-125D2	238.79	8.29	1.90	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	221.13	5.36	3.01	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	231.57	12.14	2.76	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	199.58	11.16	2.23	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	327.38	20.17	3.52	2.35
CD14+ monocytes - treated with BCG, donor2	11870-125B7	303.93	26.71	3.92	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	209.80	28.73	1.96	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	236.47	8.43	2.34	1.87
CD14+ monocytes - treated with Candida, donor2	11878-125C6	290.94	18.48	2.11	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	256.26	31.06	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	243.80	8.18	2.68	1.64
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	244.45	17.16	3.99	1.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	144.28	11.03	1.87	0.83
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	231.07	6.41	2.75	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	189.33	13.80	1.81	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	192.48	10.48	2.18	2.18
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	349.15	15.06	2.42	4.03
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	321.01	24.60	3.49	2.27
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	329.08	18.94	4.21	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	211.27	4.41	2.76	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	243.77	8.45	3.52	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	203.57	5.70	2.63	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	316.31	17.61	2.79	1.57
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	304.77	33.45	1.49	2.60
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	232.58	40.74	1.29	1.72
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	217.44	4.09	2.87	1.64
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	176.63	7.88	1.62	0.70
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	125.28	5.57	0.93	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	109.64	5.67	1.09	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	120.58	4.39	1.15	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	105.28	2.60	1.73	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	224.86	5.14	4.36	1.09
CD14+CD16- Monocytes, donor2	11799-124C8	187.22	4.02	1.75	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	254.41	4.68	3.79	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	123.25	3.83	1.02	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	119.66	3.95	1.98	0.44
CD14-CD16+ Monocytes, donor3	11911-125G3	120.01	3.16	0.42	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	99.58	6.10	6.10	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	101.02	2.71	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	95.27	5.18	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	116.74	4.26	2.67	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	106.14	5.36	2.14	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	104.59	2.81	2.81	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	104.32	1.57	2.35	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	122.60	2.64	6.59	0.00
CD19+ B Cells, donor1	11544-120B5	267.94	5.75	2.47	0.82
CD19+ B Cells, donor2	11624-122B4	253.17	5.08	4.35	2.18
CD19+ B Cells, donor3	11705-123B4	225.66	4.54	3.53	2.02
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	219.00	6.87	3.64	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	144.62	5.19	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	92.37	4.02	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	121.91	3.93	3.37	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	110.85	4.51	2.25	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	122.21	5.86	4.28	0.00
CD4+ T Cells, donor1	11225-116C1	232.44	2.86	2.50	0.00
CD4+ T Cells, donor2	11306-117C1	254.74	3.67	4.90	1.84
CD4+ T Cells, donor3	11382-118B5	248.57	3.66	2.74	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	166.67	1.28	2.04	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	163.28	1.80	1.80	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	185.41	0.86	0.57	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	129.43	1.90	1.42	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	161.53	4.21	5.62	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	230.74	3.30	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	143.07	1.88	1.73	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	215.73	1.36	3.56	1.86
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	197.64	1.77	1.61	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	127.77	0.45	2.69	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	142.90	2.10	1.75	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	154.43	0.00	2.20	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	175.82	3.79	2.95	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	195.51	1.04	3.53	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	187.11	2.34	2.34	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	183.83	1.36	4.62	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	230.46	4.29	2.68	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	245.67	7.17	5.38	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	190.43	2.41	3.34	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	162.68	1.73	1.30	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	176.53	2.10	1.47	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	143.59	5.06	1.52	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	152.94	2.60	1.30	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	187.84	1.74	1.31	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	207.35	2.47	1.98	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	143.09	1.85	4.62	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	184.25	0.00	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	205.20	4.98	4.43	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	256.68	4.66	4.66	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	214.06	3.08	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	204.49	4.30	2.15	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	207.75	0.00	5.54	0.00
CD8+ T Cells, donor1	11226-116C2	244.89	6.55	3.93	0.33
CD8+ T Cells, donor2	11307-117C2	260.55	4.88	4.13	2.63
CD8+ T Cells, donor3	11383-118B6	275.21	2.02	2.27	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	152.77	4.82	4.36	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	154.33	6.47	2.64	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	117.37	3.83	3.01	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	159.71	4.80	3.00	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	179.75	7.68	5.04	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	160.31	5.68	2.50	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	156.88	3.26	3.26	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	160.29	6.32	3.16	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	155.48	4.69	2.81	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	173.88	7.55	2.42	1.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	163.55	3.49	3.20	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	164.12	6.66	3.73	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	110.31	7.00	1.31	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	123.88	9.56	1.37	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	146.94	11.19	1.49	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	178.28	5.04	2.52	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	167.74	4.60	5.18	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	163.57	6.60	3.77	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	177.78	6.02	2.85	0.95
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	166.08	8.30	3.38	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	144.58	5.45	2.56	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	148.40	5.35	1.91	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	149.37	8.67	4.34	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	130.86	4.54	1.51	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	167.82	13.65	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	152.48	11.89	2.10	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	217.38	12.02	3.01	1.00
Cardiac Myocyte, donor1	11525-119I4	257.71	9.14	1.83	7.31
Cardiac Myocyte, donor2	11605-120I3	320.17	8.89	2.47	3.95
Cardiac Myocyte, donor3	11686-122I3	250.66	4.74	5.37	0.84
Chondrocyte - de diff, donor1	11261-116G1	271.09	5.55	10.75	0.35
Chondrocyte - de diff, donor2	11338-117F6	259.43	9.95	4.26	1.07
Chondrocyte - de diff, donor3	11410-118E6	422.58	8.65	8.19	4.10
Chondrocyte - re diff, donor2	11339-117F7	237.24	8.06	6.27	2.69
Chondrocyte - re diff, donor3	11411-118E7	465.87	5.66	5.66	3.64
Ciliary Epithelial Cells, donor1	11242-116D9	190.61	4.25	4.13	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	259.08	4.28	6.20	2.57
Ciliary Epithelial Cells, donor3	11399-118D4	246.20	3.81	6.28	1.33
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	439.70	11.55	15.77	1.93
Corneal Epithelial Cells, donor1	11526-119I5	303.23	5.71	5.05	0.44
Corneal Epithelial Cells, donor2	11606-120I4	381.10	22.75	6.83	0.00
Corneal Epithelial Cells, donor3	11687-122I4	264.32	6.90	4.35	1.79
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	401.02	30.05	8.58	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	403.72	27.44	7.89	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	231.20	27.61	6.90	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	361.55	19.65	6.80	2.81
Dendritic Cells - plasmacytoid, donor1	11228-116C4	233.00	1.37	5.81	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	239.60	5.22	4.57	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	181.48	2.42	6.29	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	255.99	4.84	6.17	0.67
Endothelial Cells - Aortic, donor1	11263-116G3	350.89	2.35	8.80	1.76
Endothelial Cells - Aortic, donor2	11340-117F8	517.52	7.35	11.88	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	391.22	3.54	13.37	1.97
Endothelial Cells - Artery, donor1	11264-116G4	602.98	8.44	10.47	3.78
Endothelial Cells - Artery, donor2	11341-117F9	422.79	4.94	13.65	1.65
Endothelial Cells - Artery, donor3	11413-118E9	344.31	4.56	7.89	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	515.56	8.64	12.86	1.33
Endothelial Cells - Lymphatic, donor2	11317-117D3	638.05	9.74	18.86	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	605.81	10.99	18.04	1.13
Endothelial Cells - Microvascular, donor1	11265-116G5	372.01	6.24	6.83	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	267.10	5.21	7.29	3.12
Endothelial Cells - Microvascular, donor3	11414-118F1	429.47	5.53	10.35	2.41
Endothelial Cells - Thoracic, donor1	11266-116G6	355.31	4.80	5.60	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	563.43	8.39	12.05	4.19
Endothelial Cells - Umbilical vein, donor1	11243-116E1	338.70	6.46	8.08	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	278.53	4.78	5.65	1.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	284.80	3.18	7.45	1.83
Endothelial Cells - Vein, donor1	11267-116G7	251.39	5.69	5.69	1.14
Endothelial Cells - Vein, donor2	11344-117G3	304.55	1.40	4.19	0.00
Endothelial Cells - Vein, donor3	11416-118F3	310.40	5.81	6.91	1.41
Eosinophils, donor1	12244-129H3	198.21	0.00	15.25	0.00
Eosinophils, donor2	12245-129H4	331.70	3.30	6.60	1.65
Eosinophils, donor3	12246-129H5	331.71	14.27	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	264.85	10.02	2.69	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	237.14	10.40	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	276.57	16.27	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	416.26	7.80	6.98	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	383.54	17.63	9.85	13.25
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	42.36	4.44	1.08	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	300.29	8.97	6.67	2.18
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	467.55	16.65	11.60	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	528.08	11.18	13.71	2.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	1746.68	29.51	30.56	9.75
Fibroblast - Aortic Adventitial, donor3	11401-118D6	393.32	8.30	8.97	1.33
Fibroblast - Cardiac, donor1	11268-116G8	359.73	14.06	8.17	4.99
Fibroblast - Cardiac, donor2	11345-117G4	241.03	3.79	3.79	0.76
Fibroblast - Cardiac, donor3	11417-118F4	446.02	12.14	9.46	2.84
Fibroblast - Cardiac, donor4	11452-119A3	297.65	7.27	5.15	0.61
Fibroblast - Cardiac, donor5	11456-119A7	304.19	3.81	9.52	2.79
Fibroblast - Cardiac, donor6	11460-119B2	288.33	3.49	7.43	1.36
Fibroblast - Choroid Plexus, donor1	11492-119E7	389.91	9.25	8.44	0.54
Fibroblast - Choroid Plexus, donor2	11572-120E6	338.67	8.63	3.45	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	325.18	4.39	7.32	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	402.00	8.07	8.53	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	342.26	9.67	10.18	1.36
Fibroblast - Dermal, donor1	11269-116G9	318.13	8.92	8.69	0.70
Fibroblast - Dermal, donor2	11346-117G5	256.59	4.72	4.25	0.47
Fibroblast - Dermal, donor3	11418-118F5	298.11	8.58	6.77	2.06
Fibroblast - Dermal, donor4	11450-119A1	195.12	4.86	4.07	1.13
Fibroblast - Dermal, donor5	11454-119A5	225.22	5.93	4.54	1.22
Fibroblast - Dermal, donor6	11458-119A9	231.62	4.22	3.57	3.25
Fibroblast - Gingival, donor1	11237-116D4	270.28	7.91	5.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	352.65	9.17	6.81	1.31
Fibroblast - Gingival, donor2	11318-117D4	204.66	4.48	5.67	1.58
Fibroblast - Gingival, donor3	11394-118C8	376.31	7.73	5.90	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	416.60	9.35	9.35	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	480.86	9.16	11.81	4.05
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	277.34	5.92	3.74	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	256.53	5.14	5.54	1.35
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	355.00	4.59	5.65	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	298.19	8.92	5.41	1.46
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	291.39	7.09	5.18	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	282.46	8.99	5.70	1.86
Fibroblast - Gingival, donor9 (control)	11927-125I1	501.55	8.95	9.54	1.32
Fibroblast - Lung, donor1	11270-116H1	210.70	2.72	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	241.73	2.98	7.46	0.00
Fibroblast - Lung, donor3	11419-118F6	314.23	6.54	5.06	2.32
Fibroblast - Lymphatic, donor1	11506-119G3	446.50	7.50	8.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	433.57	6.99	4.20	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	316.26	4.76	6.44	0.28
Fibroblast - Mammary, donor1	11540-120B1	562.67	10.96	12.59	0.81
Fibroblast - Mammary, donor2	11620-122A9	587.15	7.99	11.98	3.99
Fibroblast - Mammary, donor3	11701-123A9	601.58	17.87	11.91	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	193.00	2.72	4.27	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	255.74	4.55	7.28	1.82
Fibroblast - Periodontal Ligament, donor3	11395-118C9	291.91	8.87	5.51	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	314.08	3.82	7.25	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	337.22	8.10	6.48	4.05
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	577.55	9.16	13.22	1.86
Fibroblast - Pulmonary Artery, donor1	11250-116E8	243.83	5.08	5.75	1.33
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	458.80	10.97	10.36	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	384.22	8.02	8.69	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	291.78	7.51	6.33	2.37
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	658.65	20.44	9.33	2.78
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	414.92	9.06	7.46	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	352.19	13.01	6.70	0.99
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	829.76	26.48	10.23	4.21
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	315.76	11.98	5.07	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	498.81	8.10	9.87	3.54
Fibroblast - skin normal, donor1	11553-120C5	358.51	11.32	6.40	0.82
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	768.34	23.46	11.23	1.00
Fibroblast - skin normal, donor2	11561-120D4	307.82	9.85	4.82	1.21
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	508.06	6.95	7.25	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	361.46	10.52	6.38	0.66
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	281.38	9.57	5.98	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	985.62	21.68	16.42	2.96
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	289.63	10.55	5.75	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	252.18	8.94	4.55	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	274.59	8.63	2.82	7.84
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	530.76	27.89	6.97	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	248.07	9.71	6.24	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	201.95	8.07	5.73	1.30
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	249.12	7.67	4.60	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	222.01	13.01	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	215.03	16.59	2.55	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	234.49	12.27	6.56	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	209.02	4.41	3.58	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	206.64	5.94	4.57	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	251.43	13.67	7.13	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	195.87	4.76	6.61	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	188.19	7.18	5.87	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	221.55	18.57	4.42	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	191.63	12.30	4.95	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	240.87	14.04	4.93	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	239.61	16.12	9.40	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	171.72	8.30	2.23	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	203.90	8.72	4.01	1.94
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	193.14	9.96	3.05	2.44
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	242.33	10.04	2.05	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	236.55	6.60	6.85	2.49
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	249.18	9.84	5.90	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	199.45	9.16	4.14	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	256.56	8.27	3.97	2.70
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	258.94	7.37	7.37	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	227.44	10.48	3.43	2.62
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	253.78	7.63	6.28	2.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	243.85	13.21	5.23	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	143.70	6.24	3.02	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	133.03	8.03	2.73	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	225.84	7.52	3.32	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	195.01	10.07	4.41	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	190.91	12.66	2.86	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	193.51	7.84	2.68	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	216.98	7.72	2.42	0.69
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	222.63	8.00	2.67	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	188.47	8.60	1.76	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	224.83	6.64	3.32	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	206.83	8.10	2.59	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	173.83	10.90	1.92	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	211.87	7.58	2.75	1.04
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	185.07	9.17	1.90	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	213.47	8.21	2.74	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	231.24	9.51	2.61	1.46
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	189.48	8.56	2.85	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	221.91	7.57	3.09	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	288.96	7.22	4.07	1.67
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	224.35	10.70	3.48	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	280.15	9.95	3.98	2.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	269.57	6.87	4.27	1.42
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	262.13	9.22	1.36	2.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	314.50	14.56	5.35	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	281.38	10.31	4.39	1.32
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	287.61	9.92	2.98	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	341.78	8.84	3.96	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	313.13	11.10	3.63	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	200.28	7.12	5.34	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	177.16	12.74	2.39	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	230.19	14.79	5.24	1.08
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	265.55	16.78	4.50	1.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	151.15	10.01	3.76	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	129.98	10.45	1.41	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	153.58	6.92	1.84	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	178.19	7.42	7.42	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	231.31	13.15	2.32	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	250.30	14.44	9.63	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	253.87	10.43	6.96	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	194.96	4.56	4.23	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	203.84	14.41	0.41	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	293.24	10.00	0.00	6.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	189.60	8.39	3.64	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	207.22	10.13	3.60	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	185.38	11.74	3.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	222.97	6.68	2.86	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	176.28	7.81	2.38	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	158.70	8.35	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	183.84	9.16	2.86	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	158.35	8.29	3.55	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	137.23	1.69	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	188.88	6.63	1.24	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	180.65	7.36	2.30	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	147.52	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	173.37	6.15	3.08	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	137.56	5.22	1.30	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	113.70	3.34	2.01	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	123.67	4.24	2.31	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	179.73	7.53	2.05	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	131.69	4.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	124.10	4.72	1.42	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	130.96	6.64	3.62	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	148.53	8.65	2.03	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	134.41	7.58	1.60	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	104.10	5.92	1.48	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	114.50	3.54	1.18	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	142.36	4.08	1.17	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	106.21	6.14	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	87.31	0.85	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	141.47	7.76	0.60	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	115.97	5.34	2.91	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	263.64	3.42	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	402.93	10.40	9.98	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	150.68	5.62	4.50	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	266.73	10.78	4.44	2.85
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	261.92	12.11	6.68	2.92
Hep-2 cells mock treated, biol_rep1	11898-125E8	223.50	11.60	6.27	1.86
Hep-2 cells mock treated, biol_rep2	11899-125E9	286.46	14.85	7.93	3.04
Hep-2 cells mock treated, biol_rep3	11900-125F1	267.54	11.15	7.74	2.05
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	250.86	12.90	5.90	3.17
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	266.92	13.54	6.88	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	255.76	11.63	5.38	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	246.34	12.45	6.35	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	267.45	15.61	5.49	1.89
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	244.44	12.17	5.77	2.56
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	622.86	7.83	11.75	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	501.61	6.06	12.55	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	449.45	2.64	10.58	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	379.88	6.70	7.05	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	372.70	7.99	5.81	2.18
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	264.53	5.94	4.02	2.80
Hepatocyte, donor1	11523-119I2	686.41	10.90	15.74	3.63
Hepatocyte, donor2	11603-120I1	520.35	9.70	10.77	2.15
Hepatocyte, donor3	11684-122I1	458.31	9.82	9.20	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	117.48	1.31	1.96	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	366.69	8.21	7.34	1.75
Iris Pigment Epithelial Cells, donor1	11530-119I9	247.80	7.68	7.13	0.96
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	89.15	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	93.45	0.00	13.35	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	89.98	2.77	1.38	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	87.59	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	106.81	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	94.83	2.56	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	63.99	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	129.95	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	83.37	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	83.50	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	131.02	0.00	2.65	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	80.93	4.43	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	73.34	0.00	0.00	10.48
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	78.10	1.26	1.89	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	100.53	4.64	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	29.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	104.01	2.58	2.58	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	130.40	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	83.64	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	110.82	2.44	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	87.74	3.36	0.84	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	110.10	1.61	0.80	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	91.40	0.00	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	0.00	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	86.85	1.42	1.42	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	89.79	1.81	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	126.98	4.30	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	135.94	2.54	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	117.33	0.00	0.64	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	131.23	7.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	127.10	2.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	142.69	0.00	3.32	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	125.09	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	111.43	1.85	2.16	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	140.48	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	169.73	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	140.47	4.17	1.39	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	97.38	0.00	4.43	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	132.92	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	88.94	0.87	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	89.99	2.25	4.50	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	90.60	3.48	3.48	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	108.81	3.20	3.20	2.13
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	94.21	4.16	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	116.83	2.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	103.09	2.76	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	75.63	6.05	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	62.38	3.17	3.17	0.00
Keratinocyte - epidermal, donor1	11272-116H3	311.14	10.93	7.83	0.73
Keratinocyte - epidermal, donor2	11349-117G8	159.88	1.76	2.93	0.59
Keratinocyte - epidermal, donor3	11421-118F8	230.77	4.83	3.88	1.23
Keratinocyte - oral, donor1	11251-116E9	178.68	5.22	4.09	0.23
Keratocytes, donor1	11527-119I6	439.42	6.88	5.16	0.69
Keratocytes, donor2	11607-120I5	380.84	1.17	8.20	0.00
Keratocytes, donor3	11688-122I5	287.50	3.36	6.32	1.98
Krukenberg tumor cell line:HSKTC	10687-109F3	134.07	2.20	6.59	2.20
Lens Epithelial Cells, donor1	11529-119I8	256.74	3.24	4.31	1.08
Lens Epithelial Cells, donor2	11609-120I7	252.69	4.96	8.30	0.23
Lens Epithelial Cells, donor3	11690-122I7	590.22	13.22	12.82	0.91
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	387.39	7.11	9.01	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	327.63	4.74	5.86	1.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	420.13	5.98	8.19	3.46
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	353.28	5.38	5.91	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	388.91	7.88	6.62	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	346.95	6.15	7.98	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	379.20	5.34	6.16	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	344.09	4.55	4.55	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	357.08	7.18	9.71	2.53
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	347.67	4.35	3.16	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	347.83	5.62	6.20	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	330.12	5.18	6.11	2.04
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	381.52	7.67	8.71	4.18
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	359.93	7.63	6.92	1.91
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	374.55	7.28	5.77	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	403.12	6.16	5.24	2.77
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	323.28	4.68	5.61	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	441.92	5.12	8.78	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	384.07	6.58	7.24	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	347.35	4.39	7.03	1.76
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	436.37	5.73	6.47	1.74
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	349.66	4.36	2.91	2.42
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	330.97	7.81	5.66	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	406.75	9.08	7.57	2.27
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	374.81	7.78	6.74	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	372.92	5.03	6.91	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	400.29	6.77	8.72	1.80
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	423.04	11.01	4.13	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	333.02	3.95	6.40	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	364.74	5.51	8.59	2.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	384.75	9.21	8.24	4.36
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	335.09	5.95	4.96	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	391.00	5.70	7.56	2.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	436.48	7.77	5.92	1.85
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	324.67	4.20	4.94	1.98
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	370.27	7.15	5.77	2.47
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	396.58	7.40	6.75	3.86
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	376.76	4.87	5.78	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	402.68	5.88	8.54	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	357.34	5.69	6.76	3.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	378.13	7.76	7.27	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	407.23	5.45	11.36	2.02
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	383.17	4.30	3.94	1.79
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	394.30	7.51	7.19	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	381.15	5.18	9.89	2.59
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	393.53	5.57	9.16	1.49
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	342.19	4.87	7.17	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	380.40	6.56	5.97	2.98
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	90.64	6.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	106.63	6.14	3.07	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	124.69	7.42	0.74	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	119.32	9.31	0.85	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	137.15	7.74	2.11	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	125.15	4.67	2.80	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	117.48	9.27	4.64	3.61
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	128.46	7.14	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	97.94	5.43	2.49	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	107.32	8.43	2.62	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	117.05	7.65	2.70	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	116.38	7.99	4.06	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	125.81	7.70	5.14	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	114.33	7.41	2.12	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	121.27	9.99	2.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	108.50	5.09	1.02	3.06
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	121.40	8.00	2.13	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	123.38	9.45	3.21	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	106.76	9.20	1.84	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	125.58	8.97	0.82	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	122.66	5.00	3.12	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	105.66	6.45	2.52	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	123.64	8.24	5.15	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	121.93	7.84	2.32	2.32
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	106.12	7.17	4.48	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	108.99	7.75	1.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	144.93	6.36	3.53	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	113.95	7.38	2.58	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	97.86	5.76	1.15	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	118.58	9.59	4.99	2.69
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	93.98	9.06	3.40	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	109.94	7.38	4.10	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	131.05	8.59	1.36	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	122.08	5.75	1.44	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	147.14	6.72	3.73	2.24
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	123.00	9.29	1.11	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	118.89	8.61	2.58	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	131.87	8.56	1.71	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	140.93	8.33	2.67	2.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	123.07	9.65	2.41	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	123.00	7.82	1.42	3.55
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	125.11	5.84	3.44	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	104.67	7.51	4.29	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	114.47	4.04	3.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	136.31	8.89	4.44	2.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	75.59	6.98	1.16	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	121.64	2.12	1.06	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	145.25	6.80	2.80	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	91.59	9.45	0.73	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	105.01	6.90	3.07	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	128.25	5.92	3.45	2.47
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	100.68	3.76	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	121.68	7.04	4.53	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	128.43	6.76	2.70	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	98.10	6.88	3.44	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	111.34	4.45	2.23	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	136.08	4.69	4.30	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	106.22	9.24	1.98	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	117.80	6.75	0.52	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	122.08	7.00	3.06	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	97.84	6.71	2.80	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	114.83	5.30	3.97	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	119.19	5.40	1.54	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	95.19	6.58	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	125.44	5.77	2.40	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	118.87	5.96	1.19	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	113.02	10.33	2.43	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	84.39	2.77	4.15	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	117.80	7.60	3.04	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	94.50	7.23	2.07	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	111.86	4.23	3.63	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	101.41	8.87	5.39	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	112.48	6.93	3.73	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	87.35	9.19	2.30	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	131.13	6.69	1.54	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	99.74	13.44	2.12	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	93.64	3.40	2.27	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	116.49	7.90	3.33	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	104.93	10.18	3.13	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	88.52	8.35	3.34	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	137.07	8.83	2.32	2.79
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	114.41	8.03	4.01	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	128.85	12.83	2.67	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	124.46	8.89	2.42	4.04
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	111.97	4.59	3.67	1.84
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	104.91	7.11	0.89	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	131.64	10.26	2.28	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	108.90	11.50	3.83	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	109.98	6.57	3.83	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	121.16	4.01	2.67	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	103.46	4.68	3.38	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	120.02	9.95	2.65	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	95.62	2.08	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	679.42	27.12	9.34	2.05
Macrophage - monocyte derived, donor2	11313-117C8	486.29	45.69	9.91	2.02
Macrophage - monocyte derived, donor3	11389-118C3	767.35	54.01	7.47	5.90
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	139.66	7.43	3.19	0.00
Mallassez-derived cells, donor2	11929-125I3	309.77	10.14	5.55	0.00
Mallassez-derived cells, donor3	11930-125I4	238.36	6.12	3.89	0.28
Mammary Epithelial Cell, donor1	11273-116H4	265.75	7.77	6.98	1.20
Mammary Epithelial Cell, donor2	11350-117G9	258.57	11.00	4.92	1.45
Mammary Epithelial Cell, donor3	11422-118F9	254.66	7.73	5.49	1.25
Mast cell - stimulated, donor1	11487-119E2	117.96	2.71	0.68	0.00
Mast cell, donor1	11563-120D6	199.30	2.60	2.05	0.22
Mast cell, donor2	11565-120D8	239.82	5.94	4.16	0.30
Mast cell, donor3	11566-120D9	213.42	3.15	5.40	1.58
Mast cell, donor4	11567-120E1	240.76	4.08	6.38	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	225.00	4.44	3.55	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	128.99	5.25	1.75	1.17
Mast cell, expanded, donor5	11939-126A4	184.93	2.98	2.41	1.03
Mast cell, expanded, donor8	11941-126A6	201.34	4.35	2.18	0.50
Melanocyte - dark, donor1	11502-119F8	289.44	4.68	6.87	0.90
Melanocyte - dark, donor2	11582-120F7	327.74	4.15	6.23	4.50
Melanocyte - dark, donor3	11663-122F7	229.93	9.34	2.03	0.43
Melanocyte - light, donor1	11274-116H5	241.65	9.40	3.06	0.71
Melanocyte - light, donor2	11351-117H1	227.26	8.19	2.73	0.68
Melanocyte - light, donor3	11423-118G1	261.03	4.34	3.47	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	387.76	6.87	5.83	2.60
Melanocyte, donor2 (MC+2)	12739-135I3	311.70	9.68	4.57	2.69
Melanocyte, donor3 (MC+3)	12837-137B2	323.03	6.43	3.75	1.61
Meningeal Cells, donor1	11493-119E8	362.13	10.42	8.19	0.25
Meningeal Cells, donor2	11573-120E7	425.18	7.04	11.00	0.88
Meningeal Cells, donor3	11654-122E7	258.52	8.56	5.95	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	181.93	4.56	4.56	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	340.34	9.46	7.14	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	245.75	6.57	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	367.59	3.92	5.23	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	249.73	4.31	6.46	2.15
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	481.14	13.55	12.28	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	411.16	8.54	5.03	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	320.40	10.99	4.83	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	302.46	12.42	7.31	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	332.07	9.62	6.34	2.86
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	226.87	6.65	5.12	1.11
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	401.83	4.46	7.81	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	268.67	5.66	4.08	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	288.73	4.75	3.86	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	210.20	7.01	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	319.56	3.84	5.12	3.20
Mesenchymal stem cells - adipose, donor0	11217-116B2	214.08	2.84	4.25	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	235.79	5.32	6.88	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	227.14	2.18	3.63	0.73
Mesothelial Cells, donor1	11247-116E5	337.04	6.10	10.87	0.53
Mesothelial Cells, donor2	12156-128G5	295.28	9.51	6.01	1.00
Mesothelial Cells, donor3	11402-118D7	351.57	4.34	10.84	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	228.20	9.45	6.75	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	669.62	19.70	11.08	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	541.22	38.57	10.60	2.06
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	297.31	3.46	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	505.21	18.29	7.44	2.17
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	423.99	28.42	7.05	2.70
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	240.87	4.63	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	601.38	19.77	7.51	2.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	539.96	40.03	9.78	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	194.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	558.64	17.88	5.08	2.24
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	502.87	38.01	8.71	1.19
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	128.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	464.59	12.39	3.54	3.54
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	469.22	32.67	5.70	1.14
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	188.17	10.53	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	517.19	20.80	4.46	4.24
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	295.58	23.94	9.21	3.68
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	215.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	591.64	16.10	5.96	3.58
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	192.82	10.06	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	33.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	475.96	17.56	7.03	3.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	405.46	28.28	6.18	2.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	209.54	4.42	2.76	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	484.44	15.20	3.22	3.22
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	406.59	30.71	5.89	1.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	405.41	11.01	5.50	1.02
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	442.16	17.16	5.36	2.15
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	382.56	27.56	6.45	2.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	72.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	447.45	16.21	2.85	2.63
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	268.69	19.77	5.58	3.04
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	203.81	4.97	4.97	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	456.34	16.31	3.53	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	389.37	25.88	7.35	1.18
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	162.46	8.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	486.80	16.34	8.65	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	344.20	21.21	6.40	3.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	204.31	6.86	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	522.60	23.53	4.51	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	431.15	26.95	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	169.20	4.08	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	475.58	18.83	4.38	1.75
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	211.90	13.24	4.41	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	251.67	7.68	3.20	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	496.09	18.59	4.96	2.98
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	254.70	22.27	4.18	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	190.05	11.05	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	450.25	15.73	4.44	2.74
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	297.14	24.07	4.38	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	253.54	5.33	1.78	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	420.27	15.15	4.21	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	276.81	24.52	4.16	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	219.70	5.24	2.91	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	441.03	18.70	4.22	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	346.85	32.14	3.34	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	166.03	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	369.42	16.62	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	451.88	33.01	5.69	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	266.14	6.08	3.59	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	371.36	12.70	4.66	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	399.38	26.17	6.01	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	203.26	6.99	3.81	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	337.88	13.88	3.74	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	500.78	26.34	11.37	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	286.75	5.51	4.52	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	367.56	13.06	3.82	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	471.89	32.95	7.52	1.55
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	257.86	7.20	3.41	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	343.77	10.23	5.40	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	544.21	33.18	10.08	4.42
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	273.05	3.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	399.00	7.35	4.70	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	502.55	22.20	6.05	3.46
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	302.51	8.66	4.53	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	411.54	8.04	4.17	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	403.06	11.30	15.07	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	442.00	17.82	3.56	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	1180.89	53.89	17.41	5.91
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	994.09	58.91	10.52	14.73
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	796.08	35.78	9.69	1.98
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	1004.90	64.26	13.04	8.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	1375.19	86.75	15.02	9.39
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	1251.28	116.66	13.32	10.39
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	503.30	13.46	4.52	1.02
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	733.04	20.63	7.37	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	1116.49	49.83	13.92	6.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	1230.48	77.78	6.22	12.44
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	467.63	14.96	6.41	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	811.42	27.05	7.73	11.59
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1207.89	72.72	11.11	9.09
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	893.88	56.08	6.75	3.37
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	295.54	24.51	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	452.05	14.62	3.81	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	758.82	56.69	4.05	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	498.44	61.93	1.51	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	268.38	51.39	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	247.95	39.15	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	589.31	57.03	4.75	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	326.28	37.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	397.48	12.50	7.32	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	501.71	12.54	10.45	2.61
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	404.50	5.34	8.01	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	315.11	5.43	8.76	2.50
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	509.01	7.42	10.27	2.28
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	240.97	11.17	4.79	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	380.77	8.84	10.88	4.08
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	328.94	7.35	1.84	7.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	559.16	5.86	11.30	2.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	437.22	7.90	8.83	2.09
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	549.37	5.13	9.19	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	434.98	8.41	10.30	1.26
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	256.10	33.40	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	527.13	11.91	17.37	4.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	508.32	11.10	10.56	2.44
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	454.95	7.03	13.83	4.31
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	668.88	10.29	19.11	1.80
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	482.06	9.11	9.66	3.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	663.58	15.38	16.97	5.30
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	708.36	4.80	17.41	3.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	642.24	19.03	12.80	5.91
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	567.23	11.22	16.75	3.09
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	517.86	12.70	13.93	1.59
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	575.24	16.88	13.36	2.81
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	642.67	13.79	20.69	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	621.48	12.53	14.78	4.50
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	621.14	17.24	14.83	5.86
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	624.53	7.59	7.59	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	510.62	10.25	14.04	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	533.90	7.62	11.85	6.35
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	541.64	8.54	15.90	3.56
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	617.69	7.30	17.60	3.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	243.75	0.00	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	501.50	8.33	12.00	3.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	396.76	9.02	10.82	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	355.93	11.11	11.51	2.78
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	580.40	7.43	13.93	5.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	455.56	6.81	17.03	4.54
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	402.79	7.82	11.41	2.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	456.70	3.92	13.95	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	350.52	6.33	9.50	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	425.96	6.17	12.35	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	607.00	7.31	13.96	3.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	551.60	2.98	14.88	4.96
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	334.97	5.74	7.66	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	681.41	7.86	17.24	5.75
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	428.34	10.39	9.95	1.55
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	504.85	7.45	10.16	5.42
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	449.64	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	518.23	3.05	12.19	4.88
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	345.58	4.72	11.96	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	564.14	3.93	12.71	2.42
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	446.99	9.49	10.28	6.33
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	639.38	18.14	11.34	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	369.23	0.00	0.00	5.06
Myoblast, donor1	11241-116D8	256.66	12.17	6.21	2.11
Myoblast, donor2	11322-117D8	434.02	11.12	12.08	5.18
Myoblast, donor3	11398-118D3	355.50	15.64	10.59	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	226.34	5.98	3.79	0.58
Natural Killer Cells, donor1	11230-116C6	259.54	5.84	3.69	0.31
Natural Killer Cells, donor2	11311-117C6	286.18	6.03	5.43	2.11
Natural Killer Cells, donor3	11387-118C1	275.90	5.15	3.87	1.10
Neural stem cells, donor1	11275-116H6	296.16	9.80	9.80	0.00
Neural stem cells, donor2	11352-117H2	204.12	0.00	5.78	0.00
Neurons, donor1	11494-119E9	232.13	4.55	2.28	2.28
Neurons, donor2	11574-120E8	194.40	5.94	4.40	0.00
Neurons, donor3	11655-122E8	197.32	6.58	6.58	1.64
Neutrophils, donor1	11233-116C9	392.55	2.78	4.64	0.93
Neutrophils, donor2	11314-117C9	318.88	8.70	2.90	5.80
Neutrophils, donor3	11390-118C4	406.21	4.89	4.28	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	227.02	6.53	5.82	1.19
Nucleus Pulposus Cell, donor2	11409-118E5	294.02	7.49	4.56	3.58
Nucleus Pulposus Cell, donor3	11462-119B4	234.45	3.61	5.21	3.01
Olfactory epithelial cells, donor1	11933-125I7	310.54	6.33	7.02	2.62
Olfactory epithelial cells, donor2	11934-125I8	323.51	8.25	6.37	9.84
Olfactory epithelial cells, donor3	11935-125I9	392.27	10.67	8.40	2.50
Olfactory epithelial cells, donor4	11936-126A1	412.19	6.82	7.99	1.95
Oligodendrocyte - precursors, donor1	11496-119F2	272.02	9.03	2.41	0.60
Osteoblast - differentiated, donor1	11276-116H7	259.49	9.36	4.89	0.43
Osteoblast - differentiated, donor2	11353-117H3	406.95	16.00	14.86	5.72
Osteoblast - differentiated, donor3	11425-118G3	348.84	13.03	7.45	1.86
Osteoblast, donor1	11277-116H8	211.27	4.69	5.28	0.39
Osteoblast, donor2	11354-117H4	304.10	6.32	4.21	0.70
Osteoblast, donor3	11426-118G4	253.62	6.40	3.20	1.60
Pancreatic stromal cells, donor1	11249-116E7	306.95	11.29	7.83	1.60
Pericytes, donor1	11491-119E6	401.56	13.35	9.57	0.56
Pericytes, donor2	11571-120E5	337.96	6.79	11.54	2.49
Pericytes, donor3	11652-122E5	342.00	8.14	7.53	2.85
Perineurial Cells, donor1	11499-119F5	256.56	6.67	4.97	0.45
Perineurial Cells, donor2	11579-120F4	306.40	6.44	7.73	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	221.21	6.06	3.51	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	225.76	2.94	4.16	3.18
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	244.85	4.66	3.11	2.46
Placental Epithelial Cells, donor1	11278-116H9	201.86	9.33	4.54	0.48
Placental Epithelial Cells, donor2	11355-117H5	355.95	8.87	7.76	1.11
Placental Epithelial Cells, donor3	11427-118G5	309.02	8.83	8.64	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	438.60	12.66	9.81	9.18
Preadipocyte - breast, donor1	11467-119B9	373.49	15.94	8.44	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	428.78	10.18	6.66	0.39
Preadipocyte - breast, donor2	11328-117E5	556.12	15.76	11.26	2.70
Preadipocyte - omental, donor1	11468-119C1	486.97	20.03	11.08	1.07
Preadipocyte - omental, donor2	11329-117E6	426.87	10.91	13.97	2.18
Preadipocyte - omental, donor3	11403-118D8	572.13	12.18	13.75	3.15
Preadipocyte - perirenal, donor1	11469-119C2	473.43	19.69	14.76	5.91
Preadipocyte - subcutaneous, donor1	11279-116I1	119.78	2.46	1.23	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	250.56	5.67	5.84	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	363.22	7.83	6.64	1.87
Preadipocyte - visceral, donor1	11280-116I2	272.18	7.45	5.50	0.28
Preadipocyte - visceral, donor2	11357-117H7	320.75	7.36	6.44	1.38
Preadipocyte - visceral, donor3	11429-118G7	255.17	5.02	6.37	1.78
Prostate Epithelial Cells (polarized), donor1	11253-116F2	274.55	11.62	9.05	1.36
Prostate Epithelial Cells, donor2	11331-117E8	352.21	14.35	9.61	1.35
Prostate Epithelial Cells, donor3	11404-118D9	357.75	13.90	7.78	1.10
Prostate Stromal Cells, donor1	11254-116F3	263.45	6.49	7.63	1.71
Prostate Stromal Cells, donor2	11332-117E9	342.46	7.53	8.25	1.26
Prostate Stromal Cells, donor3	11405-118E1	432.01	8.55	9.28	3.34
Renal Cortical Epithelial Cells, donor1	11516-119H4	376.30	13.87	6.57	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	251.88	8.94	5.48	0.62
Renal Epithelial Cells, donor1	11517-119H5	299.27	7.61	5.07	0.51
Renal Epithelial Cells, donor2	11597-120H4	392.65	7.82	3.56	2.13
Renal Epithelial Cells, donor3	11678-122H4	307.22	9.00	5.40	1.06
Renal Glomerular Endothelial Cells, donor1	11514-119H2	502.47	6.81	10.21	3.40
Renal Glomerular Endothelial Cells, donor2	11594-120H1	389.47	6.74	11.05	2.70
Renal Glomerular Endothelial Cells, donor3	11675-122H1	369.20	5.55	7.33	2.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	533.02	2.66	11.31	2.00
Renal Mesangial Cells, donor1	11518-119H6	369.97	7.92	9.02	0.00
Renal Mesangial Cells, donor2	11598-120H5	368.67	11.29	11.91	0.00
Renal Mesangial Cells, donor3	11679-122H5	382.00	8.60	8.88	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	300.63	7.52	7.25	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	268.62	6.33	6.33	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	329.38	6.94	9.45	1.93
Retinal Pigment Epithelial Cells, donor0	11215-116A9	183.05	5.44	6.74	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	300.16	7.67	5.68	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	273.75	4.12	7.20	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	191.94	6.77	4.27	1.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	459.57	11.89	9.35	1.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	384.16	24.12	10.72	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	374.25	26.42	1.65	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	258.12	14.50	1.74	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	283.19	12.74	4.03	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	380.94	10.92	5.66	3.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	372.43	15.95	6.02	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	307.63	12.65	5.46	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	401.96	11.77	6.88	3.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	416.96	15.49	8.09	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	369.38	15.20	5.20	2.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	336.58	12.86	5.29	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	367.16	15.23	5.73	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	351.47	13.63	4.73	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	371.74	13.09	8.05	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	414.66	13.72	5.53	2.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	355.97	14.72	6.50	1.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	402.56	13.04	6.15	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	357.59	19.35	5.26	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	362.56	11.28	4.91	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	338.36	11.78	5.06	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	387.65	13.75	6.68	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	343.23	11.64	5.55	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	333.28	15.42	4.48	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	371.19	11.79	6.49	1.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	347.16	11.67	5.83	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	368.63	10.42	6.25	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	405.78	15.04	5.24	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	368.90	14.15	5.19	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	389.68	10.71	5.75	4.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	401.51	15.90	6.55	2.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	350.85	12.44	5.60	2.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	369.42	12.17	7.52	6.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	397.72	16.92	6.68	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	371.32	17.50	4.31	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	393.04	11.75	7.15	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	407.38	14.85	6.75	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	373.45	15.30	4.81	2.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	403.14	10.29	7.68	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	402.71	13.95	7.88	2.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	356.03	12.10	5.45	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	303.16	10.21	4.73	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	400.09	12.79	6.40	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	360.05	11.48	5.25	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	355.25	9.52	4.52	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	480.68	15.92	5.84	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	331.78	16.86	5.46	1.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	441.59	18.87	8.73	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	432.16	22.97	8.76	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	391.15	21.30	5.02	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	440.59	26.93	7.71	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	439.89	27.38	6.08	2.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	410.51	21.10	5.12	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	635.14	29.63	9.27	3.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	516.71	26.66	6.89	3.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	437.82	29.64	9.80	2.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	463.60	19.00	7.47	5.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	311.31	17.43	2.40	2.40
Schwann Cells, donor1	11498-119F4	331.38	5.08	8.09	2.07
Schwann Cells, donor2	11578-120F3	221.16	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	402.67	11.39	6.79	4.60
Sebocyte, donor1	11220-116B5	284.84	7.67	6.57	0.00
Sebocyte, donor2	11301-117B5	352.02	5.51	9.19	2.30
Sebocyte, donor3	11378-118B1	414.90	14.84	7.01	0.41
Sertoli Cells, donor1	11255-116F4	318.07	8.28	11.60	1.66
Sertoli Cells, donor2	11333-117F1	499.91	16.95	8.47	2.82
Skeletal Muscle Cells, donor1	11281-116I3	240.71	5.89	6.25	0.62
Skeletal Muscle Cells, donor2	11358-117H8	238.54	7.23	10.12	1.45
Skeletal Muscle Cells, donor3	11430-118G8	251.65	5.02	6.69	1.67
Skeletal Muscle Cells, donor4	11451-119A2	176.42	3.61	4.87	1.89
Skeletal Muscle Cells, donor5	11455-119A6	190.56	4.46	5.35	2.38
Skeletal Muscle Cells, donor6	11459-119B1	183.30	4.00	4.92	2.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	207.66	5.29	5.04	1.26
Skeletal Muscle Satellite Cells, donor2	11321-117D7	237.72	4.00	5.42	1.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	250.11	5.06	5.56	2.18
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	257.05	5.73	6.82	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	199.76	1.45	4.34	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	202.55	3.16	4.82	1.24
Skin - palm, donor1	10286-104F7	252.49	5.37	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	330.12	11.10	8.94	2.74
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	287.90	9.00	1.64	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	267.06	5.32	7.79	1.30
Small Airway Epithelial Cells, donor1	11256-116F5	234.23	6.12	5.42	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	298.90	8.58	9.56	2.53
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	368.55	11.42	7.61	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	424.37	13.12	11.47	1.80
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	53.69	7.41	1.23	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1220.82	31.35	22.01	4.45
Smooth Muscle Cells - Aortic, donor0	11210-116A4	211.62	3.53	3.53	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	337.67	5.75	8.40	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	264.23	5.12	7.09	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	196.23	6.18	6.95	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	233.18	4.00	3.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	311.93	5.99	8.38	1.33
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	359.08	7.31	4.43	2.88
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	115.48	2.30	4.99	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	254.29	8.14	6.19	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	296.80	10.04	4.43	1.48
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	290.28	5.41	6.55	1.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	420.35	10.41	9.11	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	411.59	7.31	7.00	3.04
Smooth Muscle Cells - Carotid, donor1	11285-116I7	286.15	6.31	4.29	0.76
Smooth Muscle Cells - Carotid, donor2	11362-117I3	263.19	6.12	6.12	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	204.09	0.95	5.25	2.38
Smooth Muscle Cells - Colonic, donor1	11239-116D6	248.79	5.60	5.16	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	295.09	7.75	3.87	4.95
Smooth Muscle Cells - Colonic, donor3	11396-118D1	297.45	5.04	7.87	2.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	281.21	9.28	8.51	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	208.03	8.62	4.31	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	256.72	3.89	6.87	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	368.37	8.53	9.22	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	228.52	6.44	5.73	1.18
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	277.47	8.35	9.76	0.70
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	529.97	7.74	9.78	3.87
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	221.60	6.64	6.64	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	243.20	5.56	4.50	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	282.70	5.46	6.92	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	439.40	8.64	12.15	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	245.55	7.36	5.83	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	273.20	4.82	6.18	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	326.32	6.00	7.50	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	377.33	3.88	10.34	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	207.89	4.19	6.05	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	385.73	6.06	8.58	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	308.69	7.83	8.15	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	364.62	11.21	5.31	1.18
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	282.99	6.58	6.08	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	368.12	7.01	7.01	2.34
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	259.92	7.92	6.76	0.86
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	190.45	3.06	5.35	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	210.22	3.57	2.44	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	233.37	4.19	6.15	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	277.59	4.52	7.21	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	278.09	4.76	8.57	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	245.15	11.25	5.87	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	276.41	6.63	7.07	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	136.05	2.34	3.80	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	595.91	10.30	8.36	2.53
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	430.79	17.98	6.88	3.70
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	444.10	15.25	5.58	4.46
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	505.59	18.33	7.91	4.31
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	419.04	17.32	8.80	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	285.95	8.27	4.33	3.15
Smooth muscle cells - airway, control, donor1	11966-126D4	408.10	10.16	5.33	3.30
Smooth muscle cells - airway, control, donor2	11967-126D5	523.51	4.79	6.79	1.60
Smooth muscle cells - airway, control, donor3	11968-126D6	557.20	17.56	10.87	4.18
Smooth muscle cells - airway, control, donor4	11969-126D7	604.58	15.58	10.54	2.29
Synoviocyte, donor1	11291-117A4	244.57	6.40	3.70	0.34
Synoviocyte, donor2	11368-117I9	526.68	11.06	11.06	4.36
Synoviocyte, donor3	11440-118H9	459.11	7.15	10.28	5.36
Trabecular Meshwork Cells, donor1	11532-120A2	389.49	8.58	7.15	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	327.04	3.96	5.95	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	319.07	5.56	6.71	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	153.12	3.87	1.86	0.79
Tracheal Epithelial Cells, donor2	11369-118A1	140.71	1.93	2.71	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	149.46	2.86	2.29	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	462.33	11.56	7.50	1.72
Urethra, donor2	10319-105A4	289.55	1.80	8.99	0.00
Urothelial Cells, donor1	11520-119H8	273.90	6.11	7.44	0.27
Urothelial Cells, donor2	11600-120H7	305.23	7.61	6.01	2.00
Urothelial Cells, donor3	11681-122H7	314.70	10.09	7.11	2.06
Urothelial cells, donor0	11216-116B1	250.98	4.90	6.02	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	237.57	3.56	2.67	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	260.19	7.15	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	243.69	1.37	2.05	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	207.29	4.13	2.75	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	224.86	6.97	1.16	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	253.02	1.04	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	262.49	4.59	1.84	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	236.44	3.65	1.83	1.83
Wilms' tumor cell line:G-401	10809-111A8	258.57	12.95	5.30	1.60
Wilms' tumor cell line:HFWT	10597-108E3	268.41	3.52	5.28	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	389.37	8.10	9.78	1.12
achilles tendon, donor2	10292-104G4	252.12	12.40	4.13	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	63.23	2.55	0.76	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	120.50	1.63	2.79	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	80.84	2.26	1.90	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	147.21	2.72	5.44	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	298.51	4.78	7.59	2.25
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	259.49	14.80	9.09	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	174.22	6.81	4.90	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	244.11	7.05	4.85	0.88
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	897.98	19.60	28.99	5.31
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	241.91	9.32	6.21	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	343.16	12.33	7.36	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	179.42	3.90	23.40	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	225.41	7.20	7.44	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	218.51	5.18	4.92	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	263.60	4.68	3.51	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	222.62	4.65	6.04	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	474.17	2.47	6.99	2.47
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	245.87	1.84	7.06	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	165.14	0.85	7.68	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	190.47	4.25	9.10	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	156.22	3.37	8.42	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	427.66	24.72	8.91	3.12
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	137.42	5.34	1.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	131.93	1.86	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	113.75	1.51	1.88	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	208.91	6.54	5.67	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	537.97	5.62	15.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	181.81	6.12	2.83	0.94
adipose tissue, adult, pool1	10010-101C1	347.16	13.96	8.38	1.09
adipose, donor1	10184-103D4	165.37	7.62	1.17	1.76
adipose, donor2	10185-103D5	175.59	6.08	8.92	0.41
adipose, donor3	10186-103D6	245.60	5.45	4.36	1.63
adipose, donor4	10187-103D7	318.96	6.07	1.73	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	232.00	5.68	12.63	0.79
adrenal gland, adult, pool1	10081-102A9	294.65	3.64	10.91	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	98.59	3.74	1.33	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	217.95	5.36	6.43	1.79
amniotic membrane cells, donor1	12235-129G3	291.67	12.75	5.80	2.32
amniotic membrane cells, donor2	12236-129G4	440.55	13.86	9.80	1.35
amniotic membrane cells, donor3	12237-129G5	326.42	15.61	6.19	2.36
amygdala - adult, donor10196	10167-103B5	246.65	4.74	7.11	3.56
amygdala, adult, donor10252	10151-102I7	333.35	6.08	7.71	1.42
amygdala, newborn, donor10223	10360-105E9	176.55	4.52	4.84	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	137.90	1.27	4.20	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	151.35	3.75	3.31	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	227.48	4.01	4.68	0.33
aorta, adult, pool1	10052-101G7	474.64	2.75	9.41	3.53
appendix, adult	10189-103D9	291.48	6.99	6.60	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	208.42	9.97	6.88	0.34
artery, adult	10190-103E1	199.73	5.43	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	289.44	3.33	7.10	0.14
b cell line:RPMI1788	10427-106D4	51.00	0.59	0.89	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	287.99	6.66	3.61	1.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	136.74	4.17	5.36	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	63.44	0.67	1.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	121.35	3.36	2.24	0.00
bladder, adult, pool1	10011-101C2	245.53	4.67	4.67	0.65
blood, adult, pool1	10053-101G8	274.61	0.00	6.64	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	184.11	6.85	4.28	0.86
bone marrow, adult	10192-103E3	278.70	13.50	4.05	2.70
brain, adult, donor1	10084-102B3	342.37	3.08	13.33	2.05
brain, adult, pool1	10012-101C3	295.88	5.79	8.69	1.45
brain, fetal, pool1	10085-102B4	189.67	8.01	8.01	0.00
breast carcinoma cell line:MCF7	10482-107A5	237.53	10.24	9.91	1.32
breast carcinoma cell line:MDA-MB-453	10419-106C5	90.75	0.75	2.50	0.00
breast, adult, donor1	10080-102A8	383.23	5.05	12.63	3.16
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	428.12	6.48	13.47	1.65
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	241.19	2.16	7.11	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	201.21	5.30	5.06	2.76
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	388.79	9.44	7.99	0.97
carcinoid cell line:NCI-H1770	10703-109H1	150.92	2.35	4.23	0.47
carcinoid cell line:NCI-H727	10735-110B6	105.44	2.95	3.17	0.55
carcinoid cell line:SK-PN-DW	10719-109I8	29.79	0.63	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	248.88	5.59	9.32	2.93
caudate nucleus - adult, donor10196	10177-103C6	308.55	8.06	9.21	1.15
caudate nucleus, adult, donor10252	10164-103B2	256.85	4.18	6.19	2.51
caudate nucleus, adult, donor10258	10379-105H1	226.19	5.35	6.11	0.00
caudate nucleus, newborn, donor10223	10354-105E3	231.83	12.09	4.39	1.83
cerebellum - adult, donor10196	10173-103C2	241.80	2.91	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	231.66	5.76	5.12	1.71
cerebellum, adult, pool1	10083-102B2	176.61	2.07	6.21	1.72
cerebellum, newborn, donor10223	10357-105E6	205.08	9.13	4.15	0.83
cerebral meninges, adult	10188-103D8	181.04	4.29	3.78	0.50
cerebrospinal fluid, donor2	10294-104G6	102.32	1.46	1.46	0.73
cervical cancer cell line:D98-AH2	10552-107I3	252.77	20.99	4.17	0.43
cervical cancer cell line:ME-180	10553-107I4	158.09	9.45	1.66	0.00
cervix, adult, pool1	10013-101C4	336.07	6.09	6.30	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	931.62	20.06	25.78	2.09
chondrosarcoma cell line:SW 1353	10700-109G7	201.16	1.31	6.53	0.00
choriocarcinoma cell line:BeWo	10423-106C9	172.00	5.84	3.60	0.62
choriocarcinoma cell line:SCH	10785-110H2	293.37	4.19	8.13	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	444.00	5.22	12.10	0.95
chorionic membrane cells, donor1	12238-129G6	249.02	5.13	6.27	2.28
chorionic membrane cells, donor2	12239-129G7	359.54	8.95	7.26	0.80
chorionic membrane cells, donor3	12240-129G8	246.17	3.30	6.04	3.30
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	127.24	3.03	6.06	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	190.95	5.76	6.15	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	251.73	4.01	5.28	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	93.22	2.31	2.31	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	88.53	2.66	0.73	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	85.11	2.04	3.05	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	146.34	2.36	7.07	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	196.25	2.87	3.91	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	243.67	2.29	8.46	2.29
clear cell carcinoma cell line:TEN	10636-108I6	158.41	2.95	4.68	0.35
colon carcinoma cell line:CACO-2	10513-107D9	287.01	9.70	9.34	0.73
colon carcinoma cell line:COLO-320	10420-106C6	246.67	4.94	4.94	1.14
colon, adult, donor1	10082-102B1	321.31	8.33	3.57	3.57
colon, adult, pool1	10014-101C5	303.39	3.64	4.58	0.47
colon, fetal, donor1	10070-101I7	257.70	2.47	5.56	0.00
common myeloid progenitor CMP, donor1	12130-128D6	165.01	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	115.58	6.37	2.12	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	142.78	9.81	3.77	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	152.43	7.19	3.67	0.28
corpus callosum, adult, pool1	10042-101F6	786.32	8.96	23.22	1.22
cruciate ligament, donor2	10295-104G7	223.69	2.43	3.24	1.62
diaphragm, fetal, donor1	10069-101I6	203.05	2.41	8.03	2.41
diencephalon, adult	10193-103E4	411.82	5.28	6.96	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	83.81	4.82	1.38	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	345.17	11.54	8.72	0.77
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	231.09	7.70	8.91	0.48
ductus deferens, adult	10196-103E7	362.29	6.48	8.47	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	316.85	1.44	10.08	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	347.96	5.89	8.09	3.68
dura mater, adult, donor1	10041-101F5	429.04	7.10	9.25	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	45.52	5.77	0.67	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	87.41	4.59	1.86	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	312.01	2.47	20.35	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	281.52	3.63	12.41	3.33
embryonic pancreas cell line:1C3IKEI	10606-108F3	372.04	4.94	20.99	0.93
embryonic pancreas cell line:2C6	10603-108E9	371.71	6.57	15.76	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	170.28	3.69	5.36	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	299.58	5.62	11.06	0.72
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	261.16	8.04	7.40	3.06
epidermoid carcinoma cell line:A431	10426-106D3	297.24	11.23	4.89	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	222.17	11.33	6.71	0.44
epididymis, adult	10197-103E8	562.42	6.49	14.02	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	221.94	2.13	6.39	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	291.00	7.86	9.04	1.18
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	279.79	18.08	5.37	3.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	286.50	24.90	5.51	1.87
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	293.18	21.17	6.83	2.80
esophagus, adult, pool1	10015-101C6	264.81	5.63	4.78	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	438.58	12.77	17.78	1.13
eye - muscle inferior rectus, donor1	10272-104E2	239.04	0.00	4.83	2.41
eye - muscle lateral, donor2	10298-104H1	191.48	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	148.82	1.49	4.46	0.00
eye - muscle superior, donor2	10297-104G9	251.08	2.29	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	115.13	5.83	2.91	0.00
eye, fetal, donor1	10054-101G9	231.35	3.05	4.83	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	249.78	4.36	7.18	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	187.32	3.80	6.89	0.00
frontal lobe, adult, pool1	10040-101F4	302.77	4.69	6.76	0.75
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	332.38	5.40	4.80	1.20
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	243.22	3.47	7.13	0.18
gall bladder, adult	10198-103E9	444.96	4.83	7.48	1.69
gamma delta positive T cells, donor1	11937-126A2	230.31	2.15	3.76	0.00
gamma delta positive T cells, donor2	11938-126A3	243.89	5.60	3.36	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	299.29	4.65	3.59	2.96
gastric adenocarcinoma cell line:MKN45	10612-108F9	421.84	7.16	11.80	1.35
gastric cancer cell line:AZ521	10549-107H9	160.02	7.71	6.07	0.16
gastric cancer cell line:GSS	10560-108A2	204.10	9.15	6.41	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	323.50	10.05	6.17	2.97
giant cell carcinoma cell line:LU65	10487-107B1	117.38	4.25	1.72	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	152.14	1.54	3.92	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	559.69	27.44	17.21	2.74
glioblastoma cell line:A172, tech_rep1	10444-106F3	278.66	9.92	8.55	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	269.78	9.55	7.86	0.70
glioblastoma cell line:T98G	10485-107A8	169.09	4.19	4.41	0.00
glioma cell line:GI-1	10413-106B8	370.49	15.82	12.89	0.29
globus pallidus - adult, donor10196	10175-103C4	457.03	3.64	9.48	1.46
globus pallidus, adult, donor10252	10161-103A8	548.48	5.86	10.74	2.93
globus pallidus, adult, donor10258	10367-105F7	424.45	2.74	6.85	6.85
globus pallidus, newborn, donor10223	10364-105F4	301.10	13.32	6.93	3.73
granulocyte macrophage progenitor, donor1	12131-128D7	168.85	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	142.07	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	109.76	5.23	10.45	0.00
granulosa cell tumor cell line:KGN	10624-108H3	339.20	4.80	10.56	2.56
hIPS +CCl2, biol_rep1	14383-156B9	204.77	10.56	3.21	0.46
hIPS +CCl2, biol_rep2	14384-156C1	237.32	9.15	2.29	1.83
hIPS +CCl2, biol_rep3	14385-156C2	261.50	9.66	5.15	1.93
hIPS, biol_rep1	14380-156B6	298.96	14.37	0.00	0.00
hIPS, biol_rep2	14381-156B7	226.34	13.72	3.43	2.06
hIPS, biol_rep3	14382-156B8	323.32	4.41	2.21	3.31
hairy cell leukemia cell line:Mo	10712-109I1	168.96	7.18	2.87	1.15
heart - mitral valve, adult	10205-103F7	316.01	2.99	7.47	1.79
heart - pulmonic valve, adult	10206-103F8	270.10	1.83	4.18	0.52
heart - tricuspid valve, adult	10207-103F9	242.30	0.83	4.16	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	357.10	3.67	6.73	3.67
heart, adult, diseased, donor1	10051-101G6	300.64	3.83	5.54	7.66
heart, adult, pool1	10016-101C7	198.93	1.15	4.83	0.46
heart, fetal, pool1	10046-101G1	215.73	4.42	6.88	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	481.91	5.55	11.11	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	120.11	2.38	4.76	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	367.40	18.89	7.40	2.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	368.13	18.57	9.83	5.46
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	380.16	19.10	7.17	2.93
hepatoma cell line:Li-7	10484-107A7	136.35	2.56	2.22	0.56
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	127.53	3.22	1.91	0.20
hippocampus - adult, donor10196	10169-103B7	244.15	7.57	8.52	6.62
hippocampus, adult, donor10252	10153-102I9	409.42	7.14	9.80	3.88
hippocampus, adult, donor10258	10374-105G5	245.49	7.97	1.49	0.00
hippocampus, newborn, donor10223	10363-105F3	164.96	4.23	4.93	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	222.17	14.65	3.05	3.66
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	240.53	12.76	4.91	2.75
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	245.52	15.23	4.82	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	197.35	10.15	4.51	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	186.17	5.68	2.84	5.42
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	186.01	8.73	2.66	2.66
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	157.36	5.26	4.09	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	185.91	4.74	4.09	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	192.27	7.09	3.75	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	140.42	9.71	3.55	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	187.56	7.88	5.30	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	136.01	9.43	2.69	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	241.77	13.77	8.45	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	212.24	13.26	4.42	6.88
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	201.61	13.96	4.36	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	245.70	11.65	4.96	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	229.81	10.90	5.67	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	180.91	10.49	1.50	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	163.15	8.29	7.72	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	206.90	10.91	5.00	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	172.28	8.14	3.45	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	234.50	8.49	5.06	1.80
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	207.86	12.48	6.10	2.32
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	214.63	12.55	5.38	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	256.61	13.49	5.54	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	255.90	9.98	5.42	2.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	244.99	11.84	4.90	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	213.36	8.80	2.46	4.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	212.53	6.65	3.17	2.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	216.37	10.59	3.63	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	212.54	9.83	9.31	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	213.20	5.31	5.98	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	152.38	6.93	2.82	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	218.58	8.18	6.39	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	242.31	10.60	5.30	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	240.62	6.39	6.39	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	250.92	11.83	7.25	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	205.89	12.48	1.78	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	225.86	18.54	5.37	4.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	206.60	4.89	1.22	1.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	146.40	9.76	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	174.41	10.59	2.32	2.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	194.84	10.40	6.02	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	154.16	5.43	2.53	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	139.86	5.34	2.49	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	165.88	16.71	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	178.90	6.77	2.84	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	185.34	8.89	4.58	1.89
immature langerhans cells, donor1	11904-125F5	65.38	3.87	1.21	0.24
immature langerhans cells, donor2	11905-125F6	93.47	5.54	0.79	0.79
insula, adult, pool1	10039-101F3	313.71	7.19	9.56	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	559.90	19.83	13.66	3.58
kidney, adult, pool1	10017-101C8	434.55	9.41	13.12	1.30
kidney, fetal, pool1	10045-101F9	412.81	9.69	11.39	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	297.82	3.27	7.10	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	130.36	2.35	4.15	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	127.53	5.69	4.77	0.00
left atrium, adult, donor1	10079-102A7	322.55	1.63	4.90	3.27
left ventricle, adult, donor1	10078-102A6	258.90	0.51	3.03	2.53
leiomyoblastoma cell line:G-402	10721-110A1	250.90	2.74	13.41	1.09
leiomyoma cell line:10964C	10569-108B2	504.75	17.24	15.45	8.62
leiomyoma cell line:15242A	10570-108B3	341.31	11.96	10.87	4.35
leiomyoma cell line:15425	10571-108B4	387.53	13.84	10.68	6.07
leiomyosarcoma cell line:Hs 5.T	10722-110A2	330.17	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	434.95	16.73	2.09	4.18
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	129.04	2.60	2.48	0.24
liposarcoma cell line:KMLS-1	10782-110G8	503.93	10.62	17.34	3.44
liposarcoma cell line:SW 872	10726-110A6	183.73	1.46	6.21	0.49
liver, adult, pool1	10018-101C9	449.72	6.64	9.56	0.97
liver, fetal, pool1	10086-102B5	264.34	3.76	4.70	2.82
locus coeruleus - adult, donor10196	10182-103D2	318.48	8.17	9.62	2.33
locus coeruleus, adult, donor10252	10165-103B3	388.66	7.20	6.83	2.40
locus coeruleus, adult, donor10258	10375-105G6	308.38	4.51	9.59	7.34
locus coeruleus, newborn, donor10223	10362-105F2	243.96	10.94	6.73	2.52
lung adenocarcinoma cell line:A549	10499-107C4	101.30	4.15	2.63	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	204.75	13.79	6.20	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	216.44	4.22	6.85	0.79
lung, adult, pool1	10019-101D1	375.53	9.21	6.38	1.18
lung, fetal, donor1	10068-101I5	271.99	3.71	4.85	0.57
lung, right lower lobe, adult, donor1	10075-102A3	658.92	6.42	11.00	3.67
lymph node, adult, donor1	10077-102A5	438.33	8.99	11.36	2.37
lymphangiectasia cell line:DS-1	10727-110A7	223.34	5.92	2.63	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	41.50	0.60	1.36	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	274.39	12.74	5.10	0.85
mature adipocyte, donor1	12231-129F8	297.47	2.66	7.55	0.00
mature adipocyte, donor2	12232-129F9	304.03	3.32	7.26	0.42
mature adipocyte, donor3	12233-129G1	326.44	4.03	8.53	0.71
mature adipocyte, donor4	12234-129G2	205.84	2.63	4.74	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	186.80	5.72	6.43	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	225.61	3.38	2.26	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	319.81	6.99	7.36	1.84
medial frontal gyrus, adult, donor10258	10368-105F8	240.17	5.40	3.49	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	131.36	3.41	0.85	2.99
medial temporal gyrus - adult, donor10196	10183-103D3	232.88	4.89	6.08	7.26
medial temporal gyrus, adult, donor10252	10156-103A3	371.18	6.79	7.85	3.82
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	267.75	1.93	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	169.42	7.54	2.15	0.72
medulla oblongata - adult, donor10196	10174-103C3	291.39	4.54	12.98	1.95
medulla oblongata, adult, donor10252	10155-103A2	406.67	6.97	7.59	2.48
medulla oblongata, adult, pool1	10038-101F2	456.13	9.14	11.43	1.06
medulla oblongata, newborn, donor10223	10361-105F1	331.56	10.42	4.86	4.51
medulloblastoma cell line:D283 Med	10838-111E1	179.79	4.21	4.21	1.77
medulloblastoma cell line:ONS-76	10759-110E3	120.07	1.83	3.42	0.49
melanoma cell line:COLO 679	10514-107E1	235.03	17.68	4.02	0.57
melanoma cell line:G-361	10465-106H6	128.67	2.71	1.09	0.27
meningioma cell line:HKBMM	10691-109F7	140.74	2.35	3.26	1.81
merkel cell carcinoma cell line:MKL-1	10843-111E6	271.40	11.46	8.81	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	226.04	2.59	5.70	1.30
mesenchymal precursor cell - adipose, donor1	11747-123G1	230.30	4.91	5.37	1.84
mesenchymal precursor cell - adipose, donor2	11748-123G2	272.49	6.00	4.54	1.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	282.83	7.45	8.70	2.48
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	355.68	9.41	6.88	1.97
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	415.18	12.13	7.90	3.27
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	435.19	10.41	8.33	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	529.15	19.05	11.50	4.98
mesenchymal precursor cell - cardiac, donor2	11753-123G7	460.52	9.32	11.39	3.91
mesenchymal precursor cell - cardiac, donor3	11754-123G8	250.15	5.70	4.51	1.99
mesenchymal precursor cell - cardiac, donor4	11755-123G9	326.53	8.24	8.37	2.03
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	269.87	5.98	6.26	2.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	475.92	8.89	9.22	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	276.05	6.23	6.09	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	424.14	10.47	6.28	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	306.04	6.53	5.92	2.04
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	333.93	9.35	8.63	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	334.04	4.76	8.79	2.38
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	297.30	7.07	10.26	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	251.31	7.97	6.71	4.62
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	292.15	4.03	5.68	2.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	264.08	5.51	7.62	1.93
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	527.20	3.68	7.73	2.21
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	301.90	7.15	5.15	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	275.34	6.74	3.37	4.21
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	326.98	9.13	2.28	1.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	323.57	7.42	4.60	1.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	351.28	6.02	6.02	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	373.71	8.32	8.93	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	316.32	5.41	6.59	3.06
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	388.55	7.78	8.46	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	324.20	9.82	4.32	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	322.05	6.95	5.56	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	483.04	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	377.25	6.63	9.81	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	363.21	8.70	6.92	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	398.26	7.45	8.41	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	425.33	15.40	5.87	5.13
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	350.43	10.74	3.36	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	371.72	7.37	7.37	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	384.45	12.46	8.59	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	341.80	13.67	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	346.05	5.16	10.33	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	331.61	4.22	4.55	2.92
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	309.91	2.91	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	305.45	8.53	6.93	4.80
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	300.12	5.72	3.27	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	314.47	7.39	6.61	4.66
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	256.04	12.59	10.49	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	325.86	8.94	4.97	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	276.50	4.77	4.77	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	301.23	7.12	5.93	4.74
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	307.05	6.09	7.31	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	189.37	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	243.85	5.07	5.07	3.80
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	314.21	6.21	7.93	2.76
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	328.83	6.45	8.60	4.30
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	319.34	3.99	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	416.71	0.00	10.33	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	391.17	6.11	6.52	4.07
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	406.75	12.71	11.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	304.79	7.07	5.31	6.48
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	349.73	8.73	8.42	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	379.62	5.35	1.34	10.69
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	240.08	1.18	3.55	5.91
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	243.96	0.00	2.57	10.27
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	280.87	5.51	4.82	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	199.90	5.94	4.95	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	181.68	5.61	6.73	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	187.00	1.91	3.18	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	184.57	3.22	2.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	187.53	8.72	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	197.66	6.34	6.34	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	250.04	10.32	6.68	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	207.87	13.56	13.56	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	218.28	8.24	3.29	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	194.46	3.97	3.17	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	255.70	5.52	5.19	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	301.51	6.11	7.13	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	185.69	7.74	1.55	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	270.73	5.67	9.45	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	142.94	0.93	1.62	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	196.59	12.82	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	142.31	7.50	2.16	0.41
mesothelioma cell line:Mero-25	10850-111F4	163.63	2.50	4.31	0.91
mesothelioma cell line:Mero-41	10851-111F5	208.29	2.93	5.87	0.73
mesothelioma cell line:Mero-48a	10852-111F6	368.68	14.84	6.86	1.33
mesothelioma cell line:Mero-82	10853-111F7	290.14	9.72	4.99	2.37
mesothelioma cell line:Mero-83	10854-111F8	276.27	13.28	3.23	1.19
mesothelioma cell line:Mero-84	10855-111F9	279.82	7.08	4.55	1.52
mesothelioma cell line:Mero-95	10856-111G1	383.86	10.77	7.25	1.45
mesothelioma cell line:NCI-H2052	10847-111F1	401.20	12.75	10.77	0.33
mesothelioma cell line:NCI-H226	10846-111E9	249.04	7.60	5.61	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	243.59	4.10	7.17	0.51
mesothelioma cell line:NCI-H28	10845-111E8	208.92	11.96	5.34	1.27
mesothelioma cell line:No36	10857-111G2	189.52	5.87	2.94	0.33
mesothelioma cell line:ONE58	10858-111G3	197.52	4.61	1.63	1.08
migratory langerhans cells, donor1	11901-125F2	192.88	13.63	2.69	1.34
migratory langerhans cells, donor2	11902-125F3	248.14	18.20	2.56	0.49
migratory langerhans cells, donor3	11903-125F4	198.68	19.74	3.05	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	503.43	9.14	10.77	6.20
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	312.61	8.27	7.42	2.54
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	220.91	6.45	7.60	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	107.71	4.95	2.09	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	187.56	6.28	4.99	0.55
myeloma cell line:PCM6	10474-106I6	275.55	6.72	6.13	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	113.63	6.09	3.55	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	255.37	7.06	1.57	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	220.18	6.91	4.23	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	218.64	6.91	3.24	0.37
nasal epithelial cells, donor2	12227-129F4	191.54	4.97	2.76	0.00
neuroblastoma cell line:CHP-134	10508-107D4	114.11	4.37	2.53	0.46
neuroblastoma cell line:NB-1	10539-107G8	190.27	7.11	3.74	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	309.37	10.54	6.54	1.05
neuroblastoma cell line:NH-12	10555-107I6	148.52	9.13	2.24	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	107.46	3.32	3.08	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	165.98	2.06	4.75	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	120.15	2.62	4.03	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	131.60	2.54	3.81	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	343.62	3.19	4.79	1.33
neutrophil PMN, donor1	12133-128D9	29.75	0.00	14.87	0.00
neutrophil PMN, donor2	12137-128E4	252.33	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	189.41	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	79.49	1.69	1.52	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	156.10	4.00	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	333.43	4.81	5.13	3.85
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	372.60	4.99	7.88	4.20
nucleus accumbens, adult, pool1	10037-101F1	325.18	5.34	10.87	0.66
occipital cortex - adult, donor10196	10172-103C1	232.82	12.36	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	367.93	8.32	6.17	1.61
occipital cortex, newborn, donor10223	10355-105E4	172.15	4.73	2.55	2.18
occipital lobe, adult, donor1	10076-102A4	348.73	6.82	13.38	3.94
occipital lobe, fetal, donor1	10073-102A1	220.99	3.43	6.87	0.86
occipital pole, adult, pool1	10036-101E9	325.38	5.99	7.96	0.47
olfactory region, adult	10195-103E6	317.72	4.59	7.64	2.29
optic nerve, donor1	10277-104E7	886.46	4.00	20.01	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	524.55	23.12	14.69	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	243.72	6.87	5.22	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	366.25	8.97	8.97	3.22
oral squamous cell carcinoma cell line:SAS	10544-107H4	321.00	16.75	5.31	1.04
osteoclastoma cell line:Hs 706.T	10704-109H2	357.76	9.70	9.11	2.06
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	126.14	3.74	3.74	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	459.74	30.96	8.69	0.85
ovary, adult, pool1	10020-101D2	274.11	5.77	7.60	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	202.02	7.88	5.50	1.83
pancreas, adult, donor1	10049-101G4	420.47	7.53	13.17	3.76
pancreatic carcinoma cell line:NOR-P1	10698-109G5	238.72	5.03	8.95	1.40
papillary adenocarcinoma cell line:8505C	10437-106E5	238.49	5.45	8.01	2.38
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	197.21	6.62	4.97	0.33
paracentral gyrus, adult, pool1	10035-101E8	311.54	6.77	9.34	0.73
parietal cortex, adult, donor10258	10373-105G4	254.70	2.94	7.34	0.00
parietal lobe - adult, donor10196	10171-103B9	266.16	2.82	4.70	0.94
parietal lobe, adult, donor10252	10157-103A4	295.01	7.13	5.42	4.56
parietal lobe, adult, pool1	10034-101E7	337.85	8.02	9.87	0.44
parietal lobe, fetal, donor1	10072-101I9	168.75	3.88	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	184.69	8.97	3.36	3.36
parotid gland, adult	10199-103F1	553.15	11.10	12.95	1.23
penis, adult	10200-103F2	326.03	5.37	5.37	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	66.75	2.79	1.30	0.74
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	620.22	10.05	19.38	1.89
pineal gland - adult, donor10196	10179-103C8	393.47	19.35	9.03	2.58
pineal gland, adult, donor10252	10160-103A7	336.38	11.84	6.51	1.78
pineal gland, adult, donor10258	10377-105G8	268.39	15.05	6.90	1.88
pituitary gland - adult, donor10196	10180-103C9	478.58	8.09	5.06	3.04
pituitary gland, adult, donor10252	10162-103A9	488.87	13.03	10.42	1.56
pituitary gland, adult, donor10258	10378-105G9	472.44	8.51	3.40	2.55
placenta, adult, pool1	10021-101D3	463.44	4.09	9.57	1.51
plasma cell leukemia cell line:ARH-77	10840-111E3	84.09	2.52	0.93	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	338.36	14.47	13.07	0.78
pons, adult, pool1	10033-101E6	334.11	6.46	8.00	0.52
postcentral gyrus, adult, pool1	10032-101E5	319.41	8.11	7.93	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	92.02	0.00	6.27	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	88.13	16.52	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	156.44	3.20	6.41	0.73
prostate cancer cell line:PC-3	10439-106E7	257.01	7.26	7.80	0.73
prostate, adult, pool1	10022-101D4	280.51	4.63	7.16	0.45
putamen, adult, donor10196	10176-103C5	250.46	2.83	7.32	1.65
putamen, adult, donor10252	10152-102I8	141.17	1.96	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	264.46	6.56	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	246.20	1.69	4.83	1.21
putamen, newborn, donor10223	10365-105F5	314.11	11.99	2.25	2.25
rectal cancer cell line:TT1TKB	10469-106I1	266.50	13.96	9.02	0.58
rectum, fetal, donor1	10067-101I4	208.65	6.95	8.35	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	178.08	3.60	5.30	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	48.46	2.07	2.07	0.00
retina, adult, pool1	10030-101E3	279.51	4.37	8.75	1.29
retinoblastoma cell line:Y79	10475-106I7	122.37	22.60	2.08	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	126.88	2.70	2.58	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	102.36	2.25	2.25	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	273.59	2.27	8.34	0.76
salivary acinar cells, donor1	11771-123I7	286.16	13.43	4.53	1.94
salivary acinar cells, donor2	11772-123I8	343.94	19.28	5.09	2.62
salivary acinar cells, donor3	11773-123I9	258.20	16.55	3.97	0.00
salivary gland, adult, pool1	10093-102C3	486.16	10.30	7.44	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	371.14	10.45	13.24	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	379.81	7.52	14.22	0.94
seminal vesicle, adult	10201-103F3	325.38	3.70	5.82	4.23
serous adenocarcinoma cell line:JHOS-2	10639-108I9	133.85	5.83	2.43	2.92
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	291.14	8.05	8.81	2.52
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	307.08	6.02	12.04	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	249.57	5.51	8.46	0.67
signet ring carcinoma cell line:Kato III	10436-106E4	284.50	9.39	7.41	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	160.25	8.13	4.52	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	148.25	1.42	2.84	2.84
skeletal muscle, adult, pool1	10023-101D5	160.60	7.44	3.36	0.48
skeletal muscle, fetal, donor1	10066-101I3	249.24	4.02	2.01	2.01
skin, adult, donor1	10074-102A2	637.81	20.36	6.79	6.79
skin, fetal, donor1	10065-101I2	284.68	4.42	5.05	3.16
small cell cervical cancer cell line:HCSC-1	10800-110I8	247.81	2.33	6.00	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	160.12	5.04	1.58	1.89
small cell lung carcinoma cell line:DMS 144	10841-111E4	265.61	0.96	10.99	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	229.44	9.56	3.96	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	95.38	3.22	2.90	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	342.78	8.50	8.93	0.87
small intestine, adult, pool1	10024-101D6	406.46	6.21	4.90	1.31
small intestine, fetal, donor1	10064-101I1	353.07	14.50	9.09	0.98
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	223.62	7.18	2.56	5.64
smooth muscle, adult, pool1	10048-101G3	265.43	1.29	5.69	1.81
somatostatinoma cell line:QGP-1	10781-110G7	142.32	2.95	1.61	0.80
spinal cord - adult, donor10196	10181-103D1	460.88	8.26	12.16	5.05
spinal cord, adult, donor10252	10159-103A6	371.40	7.10	8.28	1.97
spinal cord, adult, donor10258	10369-105F9	483.57	6.23	4.15	2.77
spinal cord, fetal, donor1	10056-101H2	374.44	6.10	10.37	0.61
spinal cord, newborn, donor10223	10359-105E8	322.83	10.56	5.51	3.67
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	358.90	8.07	8.21	1.19
spleen, adult, pool1	10025-101D7	316.20	7.49	6.72	0.11
spleen, fetal, pool1	10044-101F8	258.86	5.56	5.72	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	326.89	14.80	4.04	0.62
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	240.00	1.90	5.32	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	421.44	6.99	8.39	5.24
squamous cell carcinoma cell line:T3M-5	10616-108G4	172.01	3.52	3.52	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	246.62	10.92	5.29	0.56
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	109.29	0.85	1.27	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	255.96	10.15	8.46	0.85
stomach, fetal, donor1	10062-101H8	239.23	6.41	4.27	0.00
submaxillary gland, adult	10202-103F4	452.33	9.68	10.25	0.57
substantia nigra - adult, donor10196	10178-103C7	759.84	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	589.89	6.44	8.72	2.91
substantia nigra, adult, donor10258	10371-105G2	341.39	4.14	4.14	1.55
substantia nigra, newborn, donor10223	10358-105E7	290.40	8.48	7.07	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	173.32	6.88	7.57	0.69
temporal lobe, adult, pool1	10031-101E4	365.62	7.88	13.05	1.10
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	203.71	4.27	4.27	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	205.70	5.27	4.83	0.00
tenocyte, donor1	11763-123H8	554.37	13.96	9.77	4.89
tenocyte, donor2	11765-123I1	475.74	8.39	7.25	3.05
tenocyte, donor3	11768-123I4	488.54	11.86	8.53	5.56
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	200.55	7.31	4.93	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	163.55	4.01	3.24	1.08
teratocarcinoma cell line:PA-1	10807-111A6	182.72	7.75	4.34	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	275.86	6.60	7.11	1.40
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	246.19	12.48	5.29	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	271.57	18.32	4.47	1.64
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	251.44	7.17	5.86	2.93
testis, adult, pool1	10026-101D8	338.01	7.73	18.47	2.47
testis, adult, pool2	10096-102C6	481.31	11.28	24.36	5.86
thalamus - adult, donor10196	10168-103B6	462.57	4.42	7.73	3.31
thalamus, adult, donor10252	10154-103A1	556.05	6.88	11.56	3.13
thalamus, adult, donor10258, tech_rep1	10370-105G1	572.74	12.32	1.54	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	294.47	5.27	7.25	2.14
thalamus, newborn, donor10223	10366-105F6	206.54	8.63	2.30	0.58
throat, adult	10209-103G2	261.40	6.49	4.24	1.50
throat, fetal, donor1	10061-101H7	267.23	1.83	6.70	2.13
thymic carcinoma cell line:Ty-82	10803-111A2	193.96	5.96	4.57	0.60
thymus, adult, pool1	10027-101D9	269.41	8.75	6.16	0.80
thymus, fetal, pool1	10043-101F7	257.37	10.18	3.74	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	244.65	7.71	4.79	1.20
thyroid carcinoma cell line:TCO-1	10783-110G9	205.90	2.10	5.73	1.12
thyroid, adult, pool1	10028-101E1	409.08	6.81	13.06	1.31
thyroid, fetal, donor1	10060-101H6	406.83	4.48	16.08	2.90
tongue epidermis (fungiform papillae), donor1	10288-104F9	227.89	6.16	3.08	3.08
tongue, adult	10203-103F5	275.37	6.74	4.88	2.33
tongue, fetal, donor1	10059-101H5	220.30	4.34	4.34	0.79
tonsil, adult, pool1	10047-101G2	328.18	9.32	5.21	0.60
trachea, adult, pool1	10029-101E2	269.28	7.36	4.99	0.90
trachea, fetal, donor1	10058-101H4	269.29	6.16	6.54	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	295.82	6.73	4.25	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	288.14	6.48	5.98	0.51
transitional-cell carcinoma cell line:JMSU1	10492-107B6	201.97	2.51	5.01	0.47
tridermal teratoma cell line:HGRT	10694-109G1	142.69	1.90	3.81	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	281.04	9.65	11.85	0.59
umbilical cord, fetal, donor1	10057-101H3	262.90	6.26	0.00	0.00
uterus, adult, pool1	10100-102D1	349.96	6.48	8.70	1.02
uterus, fetal, donor1	10055-101H1	245.21	5.63	6.14	3.07
vagina, adult	10204-103F6	306.30	5.82	6.46	0.65
vein, adult	10191-103E2	295.70	7.23	4.82	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	100.41	3.74	1.60	0.27